Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Other Non-Current Liabilities (2016 - 2024)

BioCorRx's Other Non-Current Liabilities history spans 9 years, with the latest figure at $80190.0 for Q2 2024.

  • For Q2 2024, Other Non-Current Liabilities changed N/A year-over-year to $80190.0; the TTM value through Jun 2024 reached $80190.0, changed N/A, while the annual FY2023 figure was $53460.0, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q2 2024 was $80190.0 at BioCorRx, roughly flat from $80190.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $80190.0 in Q1 2024 and bottomed at $53460.0 in Q4 2023.